RecruitingACTRN12612000499886

Research of quality of life trends for Malignant obstructive jaundice patients with different treatment methods

Sponsor

Eastern Hepatobiliary Surgery Hospital

Enrollment

200 participants

Start Date

Mar 31, 2012

Study Type

Observational

Conditions

Malignant obstructive jaundice

Summary

The patients with malignant obstructive jaundice in advanced disease have poor quality of life according the results of literature review and clinical observations, so the main purpose of this study is the use of the QLQ-C30 scale developed by the European cancer research and treatment organizations, and the group pre-developed in patients with malignant obstructive jaundice specific item pool (QLQ-MOJ11) the class of the patient's quality of life evaluation, and analysis of these patients the survival time and the risk factors for death during hospitalization and late follow-up results, the trend of quality of life drawing class for patients with different treatment methods.

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study is looking at how the quality of life of patients with malignant obstructive jaundice changes over time depending on what treatment they receive. Obstructive jaundice happens when a tumor blocks the bile duct, causing yellowing of the skin and other problems. The study will use standard quality of life questionnaires to track how patients feel and will also look at survival rates and risk factors. You may be eligible if: - You are 18 years of age or older - You have been diagnosed with a cancer causing bile duct blockage (such as bile duct cancer, gallbladder cancer, pancreatic cancer, or duodenal cancer) - Your bilirubin level in blood is elevated (17.1 micromol/L or above) - Imaging has confirmed a bile duct blockage - You are able to give informed consent You may NOT be eligible if: - You have a history of mental illness or serious heart or lung disease - You cannot understand the questionnaires or have a language barrier - You have previously participated in this survey study Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

1.Our research group have developed the quality of life scale specific module about malignant obstructive jaundice patients (QLQ-MOJ11) on the basis of EORTC QLQ-C30 scale. So we apply both EORTC QLQ

1.Our research group have developed the quality of life scale specific module about malignant obstructive jaundice patients (QLQ-MOJ11) on the basis of EORTC QLQ-C30 scale. So we apply both EORTC QLQ-C30 and QLQ-MOJ11 scale to evaluation the quality of life for patients with malignant obstructive jaundice from admission to three months discharge. The patiernts need to fill with the scale five times over this period. We use the methods of self-evaluation and telephone follow-up to assesment the QOL of malignant obstructive jaundice patients. 2.The purpose of collecting general information on the patient is to judgment the demographic characteristics and biochemical indicators of the impact on patient quality of life and survival time. So that we can predict the risk factors with death forpatients with malignant obstructive jaundice .

Locations(1)

China

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12612000499886